Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,711 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia.
Schlösser M, Kartashev VV, Mikkola VH, Shemshura A, Saukhat S, Kolpakov D, Suladze A, Tverdokhlebova T, Hutt K, Heger E, Knops E, Böhm M, Di Cristanziano V, Kaiser R, Sönnerborg A, Zazzi M, Bobkova M, Sierra S. Schlösser M, et al. Among authors: kaiser r. Viruses. 2020 Apr 22;12(4):475. doi: 10.3390/v12040475. Viruses. 2020. PMID: 32331438 Free PMC article.
Basics of the virology of HIV-1 and its replication.
Sierra S, Kupfer B, Kaiser R. Sierra S, et al. Among authors: kaiser r. J Clin Virol. 2005 Dec;34(4):233-44. doi: 10.1016/j.jcv.2005.09.004. Epub 2005 Sep 29. J Clin Virol. 2005. PMID: 16198625 Review.
Bioinformatics prediction of HIV coreceptor usage.
Lengauer T, Sander O, Sierra S, Thielen A, Kaiser R. Lengauer T, et al. Among authors: kaiser r. Nat Biotechnol. 2007 Dec;25(12):1407-10. doi: 10.1038/nbt1371. Nat Biotechnol. 2007. PMID: 18066037 No abstract available.
Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy.
Altmann A, Rosen-Zvi M, Prosperi M, Aharoni E, Neuvirth H, Schülter E, Büch J, Struck D, Peres Y, Incardona F, Sönnerborg A, Kaiser R, Zazzi M, Lengauer T. Altmann A, et al. Among authors: kaiser r. PLoS One. 2008;3(10):e3470. doi: 10.1371/journal.pone.0003470. Epub 2008 Oct 21. PLoS One. 2008. PMID: 18941628 Free PMC article.
Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
Altmann A, Sing T, Vermeiren H, Winters B, Van Craenenbroeck E, Van der Borght K, Rhee SY, Shafer RW, Schülter E, Kaiser R, Peres Y, Sönnerborg A, Fessel WJ, Incardona F, Zazzi M, Bacheler L, Van Vlijmen H, Lengauer T. Altmann A, et al. Among authors: kaiser r. Antivir Ther. 2009;14(2):273-83. Antivir Ther. 2009. PMID: 19430102
Evolution of raltegravir resistance during therapy.
Sichtig N, Sierra S, Kaiser R, Däumer M, Reuter S, Schülter E, Altmann A, Fätkenheuer G, Dittmer U, Pfister H, Esser S. Sichtig N, et al. Among authors: kaiser r. J Antimicrob Chemother. 2009 Jul;64(1):25-32. doi: 10.1093/jac/dkp153. Epub 2009 May 14. J Antimicrob Chemother. 2009. PMID: 19447792
[Resistance screening].
Sierra S, Lengauer T, Kaiser R. Sierra S, et al. Among authors: kaiser r. MMW Fortschr Med. 2009 Apr 30;151(18):72, 74-5. MMW Fortschr Med. 2009. PMID: 19769083 German. No abstract available.
1,711 results